Skip to content
Search Classifications
Search for IPC and CPC classification codes or keywords
CPC Main Group Additional Only
C07K 2319/00

Fusion polypeptide

17 direct subcodes

Child Classifications

Navigate with arrow keys, Enter to open

  • C07K 2319/30 Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
  • C07K 2319/31 fusions, other than Fc, for prolonged plasma life, e.g. albumin
  • C07K 2319/32 fusions with soluble part of a cell surface receptor, "decoy receptors"
  • C07K 2319/33 fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
  • C07K 2319/35 containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
  • C07K 2319/50 containing protease site
  • C07K 2319/55 containing a fusion with a toxin, e.g. diphteria toxin
  • C07K 2319/60 containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
  • C07K 2319/61 containing an enzyme fusion for detection (lacZ, luciferase)
  • C07K 2319/85 containing an RNA binding domain
  • C07K 2319/95 containing a motif/fusion for degradation (ubiquitin fusions, PEST sequence)

Top Applicants

Top 10 applicants by patent filingsfor class C07, 2013–2023, worldwide · Source: EPO PATSTAT

  1. ROCHE CH 12,683
  2. NOVARTIS CH 10,775
  3. CHINESE ACADEMY OF SCIENCES 10,619
  4. BASF (BADISCHE ANILIN & SODA FABRIK) DE 9,511
  5. REGENERON PHARMACEUTICALS US 8,426
  6. BRISTOL-MYERS SQUIBB COMPANY US 7,979
  7. LG CHEM KR 7,978
  8. HARVARD UNIVERSITY US 7,706
  9. UNIVERSITY OF CALIFORNIA US 7,455
  10. SINOPEC (CHINA PETROCHEMICAL CORPORATION) 7,219